Literature DB >> 6287672

Spanish adulterated oil matter. An important discovery by Spanish toxicologists: the toxicity of anilides of unsaturated fatty acids.

E Fournier, M L Efthymiou, A Lecorsier.   

Abstract

Collective intoxication resulting from the addition of aniline in adulterated vegetal oils which were re-treated in order to make them available for consumption, was clinically characterized by polyneuritis, atypical pneumonia, symptoms of vascularity. After studying the infection and allergic syndrome, the toxicological approach presented a set of experimental clinical arguments in favor of a specific toxicity of anilides of unsaturated fatty acids. The toxicokinetics of oleylaniline shows a half life of several weeks, which explains its evolution. Its mode of action involves peroxide formation, membrane toxic and attractive substances of immunocompetent cells. Peroxide formation could result from an excess of superoxide ions, an inhibition of superoxide-dismutases, an excessive consumption of NADPH or more often of any facilitation of lipid peroxidation by a biologically active peroxidized intermediate.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287672

Source DB:  PubMed          Journal:  Toxicol Eur Res        ISSN: 0249-6402


  3 in total

1.  Bioassay screening for toxicants in oil samples from the toxic-oil syndrome outbreak in Spain.

Authors:  W E Turner; R H Hill; W H Hannon; J T Bernert; E M Kilbourne; D D Bayse
Journal:  Arch Environ Contam Toxicol       Date:  1985-05       Impact factor: 2.804

2.  Decrease of 12-hydroxyeicosatetraenoic acid production in mouse lungs following dietary oleic anilide consumption: implications for the toxic oil syndrome.

Authors:  S H Yoshida; B A Bruenner; J B German; M E Gershwin
Journal:  Arch Environ Contam Toxicol       Date:  1995-05       Impact factor: 2.804

3.  Effect of fatty acid anilides on immune responses of Swiss mice.

Authors:  R Blasco; V Ruiz-Gutierrez
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.